Phase 2 Hypoxic-ischemic encephalopathy. Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
Hypoxic-ischemic encephalopathy.
ReAlta Life Sciences, Inc.70 enrolled15 locationsNCT05778188
Recruiting
Phase 2
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
Neonatal EncephalopathyNeonatal AsphyxiaHypoxic-ischemic encephalopathy.
Pharmazz, Inc.40 enrolled4 locationsNCT05514340
Recruiting
Phase 2
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
Neonatal EncephalopathyNeonatal SeizureSeizure Newborn+1 more
University of California, San Diego133 enrolled5 locationsNCT05610085